Diabetes Drug Discoveries 2009: what the future holds
| Product Code | ESP00588 |
| Publication Date | February 2009 |
| Publisher | Espicom |
| Product Type | Report |
| Pages | 160 |
| ISBN Number | not applicable |
Diabetes Drug Discoveries 2009: what the future holds
This strategic report from Espicom puts the spotlight on current and future drugs that will be used in the treatment of Type I and Type II diabetes, providing industry and investors with a comprehensive overview of the market in the medium term.
Contents
Related products
| World Diabetes Drug Market 2011-2021 Where will revenue growth occur in the diabetes treatment market? Our new report shows you the potential that drug market offers from 2011 to 2021, explaining the opportunities there. Our report... |
| China Diabetes Market Report and Outlook For 2010-2015 As the second largest economy of the world, China enjoys pink of health but its affluence is giving rise to another sickness- a rapid increase in a life-style disease called... |
| Diabetes Drug Discoveries What the Future Holds The diabetes market will grow significantly over the next 5 years to US$31.4 billion - who are the companies and what are the market trends and products that will drive... |
| CNS Drug Discoveries: Alzheimer's Disease Chapter Alzheimer's disease By 2014, there will be considerable change in the Alzheimer's disease (AD) market due to generic competition, better utilisation of acetylcholinesterase inhibitors and new product launches which, for the... |
| Top 10 Medical Equipment Trends in 2009 Top 10 Medical Equipment Trends in 2009 Summary Global Markets Direct's Top 10 Medical Equipment Trends in 2009 report an essential source of information and analysis that will help answer questions like:... |
| Diabetes, Metabolic Syndrome and Cardiovascular Disease There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a... |
| Multiple Sclerosis Drug Discoveries What the future holds The recent approval in the US of Novartis’ orally administered Gilenya (fingolimod) heralds a new phase in the treatment of Multiple Sclerosis (MS). ... |
| CNS Drug Discoveries: Parkinson's Disease Chapter Parkinson's disease In 2007, approximately US$3.6 billion was spent on the symptomatic treatment of Parkinson's disease (PD). Although this neurodegenerative disease affects approximately 1% of the population its prevalence increases... |
| CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder (ADHD) Attention Deficit Hyperactivity Disorder (ADHD) The value of the ADHD market was US$2.4 billion in 2004 and it is now the 9th largest segment of the CNS market by sales and... |
| The US Pharmaceutical Market 2009-2024 What will happen next in the world's largest pharma market? Our new market study explains, letting you know the implications of change - Including over 65 tables, graphs and figures The... |
| BRIC Diabetes Drugs Market Report Description The prevalence of diabetes is on the rise across the globe due to increased life expectancy, changing lifestyles, and the rising incidence of obesity. Brazil's diabetes drugs market is... |
| Gastric Cancer Drug Discoveries what the future holds Original analysis of the clinical potential and commercial prospects for companies, launched products and pipeline candidates put into current market context.The market is set for rapid and significant growthThere is... |
| Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015 A comprehensive examination of trends and advances in the two major drug delivery sectors Unique sales forecasts to 2015 for key technology areas ... |
| CNS Drug Discoveries: Depression Chapter Depression Antidepressants accounted for around 21% of the total CNS drug sales in 2007, with sales of US$19.4 billion. However, we anticipate that within our forecast period to 2014, the... |
| CNS Drug Discoveries: Schizophrenia Chapter Schizophrenia The antipsychotic market generated global sales of US$19.6 billion, accounting for 21% of global CNS sales in 2007. While atypical antipsychotics now account for over 80% of global sales,... |
| Drug Delivery Technology: Revolutionizing Diabetes Treatment The efficient delivery of insulin remains one of the key therapeutic problems in the management of diabetes. Treatment of Type 1, and up to one-third of Type 2 cases... |
| Drug Delivery Technology Revolutionizing Diabetes Treatment The efficient delivery of insulin remains one of the key therapeutic problems in the management of diabetes. Treatment of Type 1, and up to one-third of Type 2 cases... |
| Ion Channel Drug Discovery Therapeutic Opportunities & Technology Progress Increased knowledge of novel targets in combination with a strong progress in drug discovery technologies has strongly contributed to the fast development in ion channel drug discovery that we are... |
| Global Diabetes Market Trends & Future Forecast Diabetes Drug (Anti-Diabetic Drug), Insulin, DPP-IV, GLP-1 Report Details "Global Diabetes Market Trends & Future Forecast - Diabetes Drug (Anti-Diabetic Drug), Insulin, DPP-IV, GLP-1" report published by Renub Research provides an in-depth analysis of the past, present and... |
| Home Healthcare Equipment Market to 2017 Increased Prevalence of Chronic Diseases in The Elderly Population to Stimulate Growth Home Healthcare Equipment Market to 2017 - Increased Prevalence of Chronic Diseases in the Elderly Population to Stimulate Growth Summary GBI Research's report, "Home Healthcare Equipment Market to 2017 - Increased Prevalence... |
| Drug and Device Combination 2009 - 2014 Drug device combination is defined as the combination of drugs and medical devices that can be chemically or physically united or co-packaged as separate, cross labeled products. The commercialization cycle... |
| Blood Cancer Drug Discoveries What the Future Holds This New Strategic Report from Espicom Provides A Comprehensive Review of Current and Future Treatments for Major Blood Cancer Therapy Areas: Chronic Lymphocytic Leukaemia, Chronic Myeloid Leukaemia, Acute Myeloid Leukaemia,... |
| Convergence of Biomarkers and Diagnostics, The Therapy Area Analyses, Key Products and Future Trends In recent years, there have been concerted efforts to enhance the precision of disease diagnosis and monitoring as the hetrogeneity of conditions becomes increasingly understood. Targeting broad patient populations in... |
| Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs 2010 This new report provides a complete review of the emerging opportunities and operating environment for inhalation and nasal spray drugs. It reviews products currently available generically and assesses the prospects... |
| Cardiovascular Drug Discoveries What the Future Holds Cardiovascular disease is a global problem. In the developed world, its prevalence is linked to our increasingly unhealthy lifestyle, with risk factors including lack of exercise, overweight and obesity, and... |
| Type 1 Diabetes - Drug Pipeline Assessment and Market Forecasts to 2017 Type 1 Diabetes - Drug Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released a new report, "Type 1 Diabetes - Drug Pipeline Assessment and Market... |
| Indian Diabetes Market Report and Outlook For 2010-2015 With around 51 Million diabetes patients, India promises to be amongst the most lucrative diabetes markets in the world. In 2009, the total sales of Insulin and Non-Insulin Anti-diabetics reached... |
| CNS Drug Discoveries: what the future holds Unique market share and sales forecasts by product to 2014 A comprehensive examination of 5 major CNS therapy areas Detailed competitor analysis of current and upcoming products Five key CNS sectors Alzheimer's... |
| Breast Cancer Drug Discoveries What the future holds In 2010, almost 50% of breast cancer sales were due to three branded targeted therapies. With a large unmet clinical need, further agents are required to increase survival and delay... |
| Hematology Reagents and Analyzers Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData's new report, "Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global hematology market. The... |
| Hepatitis C Market Forecast IntroductionThe Hepatitis C market was worth $2.3 billion in 2007, declining at a CAGR of -2.8% from 2004-2007. Despite this recent slump, Datamonitor forecasts sales to grow to $4.5 billion... |
| Hepatitis B - Pipeline Review Q1 2011 Hepatitis B - Pipeline Review, Q1 2011 Summary Global Markets Direct's, 'Hepatitis B - Pipeline Review, Q1 2011', provides an overview of the Hepatitis B Infection therapeutic pipeline. This report provides information... |
| Multi-client Study: Opportunities Assessment for Hepatitis C Therapeutics Market in India Better Understanding of Diagnosis Enables the Rollout of Novel Treatments Options in the Hepatitis C Therapeutics Market in India Ongoing efforts to raise disease awareness in India have increased the number... |
| Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 GlobalData's has released its pharmaceutical and healthcare report, "Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and... |
| Infectious Immunology Reagents, Instruments and Test Kits Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData's new report, "Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global... |
| Multi-Client Study: Opportunities Assessment for the Hepatitis C Therapeutics Market in the Philippines Imminent Launch of Small-molecule Antiviral Drugs Poised to Improve Treatment Success Rates for Hepatitis C Patients Efforts to raise disease awareness have increased the number of diagnosed cases and expanded the... |
| Hepatitis B Drug Pipeline Analysis and Market Forecasts to 2016 GlobalData's report, "Hepatitis B - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global hepatitis B market. The report identifies... |
| Stakeholder Opinions: Hepatitis C Small-Molecule Antivirals Pave The Way for Triple Therapy Introduction Research and Development activity in the Hepatitis C arena continue to be high. The market still holds many areas of unmet medical needs: while existing therapies provide good efficacy for... |
| Opportunities Assessment for Hepatitis B Therapeutics in Thailand This research service aims to provide an update on the epidemiology of hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and... |
| Pipeline Insight: Cancer Overview Gastrointestinal, Skin, Sarcomas Introduction In 2008, the six tumor types covered in this report are forecast to account for over 961,000 new cases of cancer. Collectively, the 32 different drugs in Phase III development... |
| Meningitis Preventive Vaccines Pipeline Analysis and Market Forecasts to 2017 Meningitis Preventive Vaccines - Pipeline Analysis and Market Forecasts to 2017 GlobalData, the industry analysis specialist, has released its new report, 'Meningitis Preventive Vaccines - Pipeline Assessment and Market Forecasts to... |
| Asthma Pipeline Assessment and Market Forecasts to 2017 Asthma - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, "Asthma - Pipeline Assessment and Market Forecasts to 2017". The report is... |
| Hemophilia Pipeline Assessment and Market Forecasts to 2017 Hemophilia - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, ""Hemophilia - Pipeline Assessment and Market Forecasts to 2017"". The report is... |
| Opportunities Assessment for Hepatitis B Therapeutics Market in Indonesia Asian Markets to Witness Growth in Anti-virals for Hepatitis B Therapeutic Treatment Set-Off by a Rising Urban Population The prevalence of hepatitis B in Indonesia is anticipated to decline gradually in... |
| Travel Vaccines Market to 2017 Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market Summary GBI Research, the leading business intelligence provider, has... |
| Renal Dialysis Equipment Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData's new report, "Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global renal dialysis equipment market.... |
| Hepatitis C (HCV) – Pipeline Assessment and Market Forecasts to 2016 Hepatitis C (HCV) - Pipeline Assessment and Market Forecasts to 2016 Summary GlobalData, the industry analysis specialist, has released a new report, "Hepatitis C (HCV) - Pipeline Assessment and Market Forecasts to... |
| Melanoma Therapeutics Pipeline Assessment and Market Forecasts to 2017 Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, ""Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017"". The... |